Vivos Therapeutics, Inc. (VVOS)

CIK 1716166 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Vivos Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 8, 20268-K0001493152-26-041616
Sep 8, 20268-K/A0001493152-26-041807
Sep 3, 2026SCHEDULE 13G/A0001851416-26-000030
Aug 26, 202640001493152-26-040238
Aug 21, 20268-K0001493152-26-039736
Aug 14, 2026SCHEDULE 13G/A0001172661-26-003625
Aug 14, 202610-Q0001493152-26-038336
Aug 11, 20268-K0001493152-26-037173
Aug 11, 2026SCHEDULE 13G0001851416-26-000026
Aug 3, 20268-K0001493152-26-035867
Jul 15, 202630001193125-26-304807
Jul 15, 2026SCHEDULE 13D0001104659-26-083931
Jul 15, 202640001193125-26-304815
Jul 7, 20268-K0001493152-26-032387
Jun 25, 20268-K0001493152-26-030190
Jun 16, 20268-K0001493152-26-028912
Jun 16, 20268-K0001493152-26-028775
Jun 8, 20268-K0001493152-26-027641
May 20, 202610-Q0001493152-26-024650
May 15, 2026NT 10-Q0001493152-26-023733
May 15, 2026SCHEDULE 13G0001172661-26-002126
May 8, 2026424B30001493152-26-022022
May 8, 2026EFFECT9999999995-26-001555
Apr 30, 2026S-3/A0001493152-26-019693
Apr 22, 20268-K0001493152-26-018562